Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

First-line therapy in ovarian cancer: Where do we stand and how do we move forwards?

How molecular biology influences radical surgical treatment in first-line ovarian cancer

Date

17 Oct 2020

Session

First-line therapy in ovarian cancer: Where do we stand and how do we move forwards?

Topics

Pathology/Molecular Biology

Tumour Site

Ovarian Cancer

Presenters

Nicole Concin

Authors

N. Concin

Author affiliations

Department Of Gynecology And Obstetrics, Medical University of Innsbruck, 6020 - Innsbruck/AT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

17 Oct 2020

Current systemic treatment for first-line

Presenter: Antonio González Martín

Session: First-line therapy in ovarian cancer: Where do we stand and how do we move forwards?

Resources:

Slides

Webcast

17 Oct 2020

Future options

Presenter: Kathleen Moore

Session: First-line therapy in ovarian cancer: Where do we stand and how do we move forwards?

Resources:

Slides

Webcast

17 Oct 2020

Q&A and live discussion

Presenter: Isabelle Ray-Coquard

Session: First-line therapy in ovarian cancer: Where do we stand and how do we move forwards?

Resources:

Webcast